International Stem Cell Provides Update of Its Parkinson's Disease Program
International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products today provided an update on the status of Parkinson's disease preclinical program. The program continues to progress on the plan developed with input from the FDA. To date no adverse events or pathological reactions have been observed in any of the completed preclinical pharmacology/toxicology studies. Results from these studies will form the basis of the regulatory submission requesting authorization to administer the drug in humans that ISCO expects to submit prior to the end of the year.
http://www.marketwired.com/press-rel...co-1952949.htm |
Stemgenex offers stem cell treatment for Parkinson's now!
http://stemgenex.com/press/stemgenex...linical-study/ |
Quote:
|
Quote:
|
Stemgenex
Quote:
|
Quote:
http://regressing.deadspin.com/what-...eck-1502352128 |
Quote:
Researchers at Cedars-Sinai Medical Center in Los Angeles, who pioneered the Parkinson's procedure, claim to have isolated and nurtured adult stem cells from their patient's brain. Dr Michel Levesque, who led the study, said: 'This is the first case that shows a promising technique may work.' Although the operation was carried out two years ago, details were only revealed yesterday at a meeting of the American Association of Neurological Surgeons in Chicago. Read more: http://www.dailymail.co.uk/health/ar...#ixzz3FaEsNCZR Follow us: @MailOnline on Twitter | DailyMail on Facebook http://www.dailymail.co.uk/health/ar...arkinsons.html |
All times are GMT -5. The time now is 04:39 AM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.